-
Mouse Neutrophil Cell Isolation Kit Workflow
2026-08-24
Build a rapid, column-free workflow for high-purity mouse neutrophils from bone marrow, blood, or spleen while minimizing target-cell labeling and unwanted activation. The approach is especially useful for functional assays that test neutrophil-targeted mRNA nanovaccines and tumor-immunity mechanisms.
-
LRPPRC–Dasatinib Dual OXPHOS Disruption
2026-08-24
The reference study identifies dasatinib as a synergistic partner for LRPPRC inhibition and explains the effect through complementary suppression of nuclear- and mitochondrial genome-encoded OXPHOS programs. Its findings support a dual-genome strategy for testing OXPHOS-dependent cancers while highlighting the need for in vivo validation and biomarker-guided combination studies.
-
Viral RIPK3 Degradation Controls Necroptosis
2026-08-23
Liu and colleagues identify a viral inducer of RIPK3 degradation (vIRD) that hijacks the host SCF ubiquitin ligase machinery to drive proteasome-dependent loss of RIPK3 and suppress necroptosis. Genetic, virological, and mouse experiments show that this mechanism regulates orthopoxvirus replication, inflammation, and mortality, providing a mechanistic link between pathogen evolution and inflammatory cell death.
-
Annexin V-FITC/7-AAD Apoptosis Kit: Signal to Decision
2026-08-22
The Annexin V-FITC/7-AAD Apoptosis Kit converts phosphatidylserine exposure and membrane permeability into a practical cell death analysis. This article shows how findings on rapid microwave processing can sharpen assay timing, controls, and interpretation without confusing a phenotypic readout with a mechanistic diagnosis.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-22
Saito and colleagues established a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be propagated, cryopreserved, and differentiated into epithelial cells with intestinal drug-metabolizing enzyme and transporter activities, providing a more human-relevant platform for oral drug pharmacokinetic studies.
-
SB743921: From Mitotic Arrest to Translational Insight
2026-08-21
SB743921 is a highly selective kinesin spindle protein inhibitor that offers more than a potent antiproliferative phenotype. By pairing its mitotic mechanism with disciplined viability and cell-death measurements, translational researchers can improve assay interpretation, model selection, and the path from cancer research to preclinical decision-making.
-
Rotigotine Workflows for Parkinson’s Disease Research
2026-08-20
Build reproducible Rotigotine experiments around receptor pharmacology, solvent control, and exposure pattern rather than dose alone. This guide connects cell-based assays, PD animal models, bladder-function studies, and continuous-delivery concepts to practical troubleshooting decisions.
-
Polybrene: From Gene Delivery to Mechanistic Rigor
2026-08-20
Polybrene (Hexadimethrine Bromide) is more than a transduction additive: it is a controllable variable in cell-engineering workflows. This thought-leadership guide connects its electrostatic mechanism with rigorous validation strategies and uses recent TCAIM–OGDH research to show why delivery optimization must remain distinct from downstream metabolic interpretation.
-
AZD1390 ATM Kinase Inhibitor Workflows
2026-08-19
Use AZD1390 to separate ATM-dependent checkpoint signaling from broader replication-stress phenotypes in glioma and lung cancer models. This workflow combines radiation-response assays with emerging REV1–DHX36 and G-quadruplex biology while clearly distinguishing validated applications from exploratory designs.
-
FLAG tag Peptide: Assay Design for HDAC Complexes
2026-08-19
Discover how the FLAG tag Peptide (DYKDDDDK) can support controlled recombinant protein detection, affinity elution, and mechanistic HDAC-complex assays. This guide connects peptide-based workflow design with the structural and biochemical insights of the Sin3L/Rpd3L study.
-
CLCC1 and Herpesvirus Nuclear Egress
2026-08-18
The herpesvirus nuclear egress preprint identifies the host protein CLCC1 as an essential factor in the membrane-fusion step that releases capsids from the perinuclear space. Its CRISPR-based findings connect viral egress with nuclear pore complex insertion and provide a mechanistic framework for studying host-dependent herpesvirus replication, while remaining distinct from drug or clinical efficacy studies.
-
TMAO Activates PERK in Fatty Liver Disease
2026-08-18
The reference study shows that dietary trimethylamine N-oxide (TMAO) can directly induce steatosis, inflammation, liver injury, and fibrosis in zebrafish, with corroborating evidence from HepG2 and hepatic stellate cell models. Its main contribution is to connect TMAO exposure with activation of the PERK branch of endoplasmic reticulum stress, while also highlighting the need for causal inhibition studies.
-
Firefly Luciferase mRNA: A Decision Framework
2026-08-17
Firefly Luciferase mRNA (ARCA, 5-moUTP) is more than a light-producing reporter: it is a tool for separating delivery, translation, viability, and storage effects. This article develops an evidence-based framework for assay design using product specifications and mRNA nanoparticle research.
-
Dextrose in Hypoxia–Immunometabolism Assays
2026-08-17
Dextrose (D-glucose) can function as a controlled metabolic input rather than merely a media ingredient. This guide shows how to use it to separate nutrient availability, oxygen stress, and immune-cell competition in more interpretable glucose metabolism research.
-
Pertussis toxin B7273 for Reliable Cell Assays
2026-08-16
Learn how Pertussis toxin, SKU B7273, can be incorporated into cell viability, proliferation, and immune-signaling workflows without confusing metabolic effects with cell death. This scenario-driven guide covers assay compatibility, protocol optimization, data interpretation, and practical product-selection criteria.